SUNPHARMA - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Technical Rating: 3.8

Here’s a detailed technical analysis of Sun Pharmaceutical Industries Ltd. (SUNPHARMA)

📊 Trend Overview

Current Trend: Mild Uptrend with Consolidation Signals

Price is above 50-DMA (₹1,692) and near 200-DMA (₹1,702) — suggests stability with bullish undertone.

RSI (58.6) — bullish zone, but not overbought.

MACD (5.11) — positive, indicating upward momentum.

Volume: Slightly below 1-week average — neutral sentiment.

📈 Chart Patterns & Indicators

Moving Averages

Price > 50-DMA and ≈ 200-DMA → bullish structure with consolidation.

No crossover signals — trend continuation likely.

Bollinger Bands

Price near mid-band — no breakout or squeeze, but volatility is contained.

Support Levels

₹1,692 – ₹1,702 (DMA zone)

₹1,660 – ₹1,675 (trendline support)

₹1,553 (52-week low)

Resistance Levels

₹1,735 – ₹1,760 (recent swing highs)

₹1,800 – ₹1,820 (psychological resistance)

₹1,960 (52-week high)

🔍 Momentum Signals

Short-Term Bias: Bullish to Neutral

RSI > 55 and MACD positive — momentum intact.

No bearish divergence or reversal pattern.

Volume Trend: Slight dip — suggests consolidation rather than breakout.

🎯 Entry & Exit Zones

Action Price Zone (₹) Rationale

Buy Entry ₹1,692 – ₹1,710 Near DMA support, bullish indicators

Exit Target ₹1,760 – ₹1,800 Resistance at swing highs

Stop Loss ₹1,675 Below trendline and DMA zone

🧠 Summary

SUNPHARMA is currently consolidating within a bullish structure, supported by strong fundamentals and technical indicators. A tactical entry near ₹1,692–₹1,710 could offer a short-term swing toward ₹1,760–₹1,800. Watch for volume confirmation and RSI strength to validate breakout potential.

Want to explore how SUNPHARMA stacks up against other pharma majors or dive into sector rotation strategies? I’ve got plenty of insights to help you stay ahead.

Edit in a page